Entourage Health Corp Stock Today
| ETRGF Stock | USD 0 0.0009 25.00% |
Performance3 of 100
| Odds Of DistressOver 61
|
Entourage Health is trading at 0.0045 as of the 19th of January 2025. This is a 25.00% increase since the beginning of the trading day. The stock's lowest day price was 0.0038. Entourage Health has more than 61 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 19th of January 2025. Click here to learn more.
Entourage Health Corp. engages in the production and distribution of cannabis products for medical and adult-use markets in Canada. The company was formerly known as WeedMD Inc. and changed its name to Entourage Health Corp. in July 2021. Entourage Health is traded on OTC Exchange in the United States.. The company has 306.74 M outstanding shares. More on Entourage Health Corp
Moving together with Entourage Pink Sheet
Moving against Entourage Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Entourage Pink Sheet Highlights
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Entourage Health Corp [ETRGF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.61 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Entourage Health's market, we take the total number of its shares issued and multiply it by Entourage Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Entourage Health Corp classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 306.74 M outstanding shares.
Entourage Health Corp has accumulated about 14.15 M in cash with (30.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Entourage Health Probability Of Bankruptcy
Ownership AllocationEntourage Health holds a total of 306.74 Million outstanding shares. Entourage Health Corp retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Entourage Ownership Details
Entourage Health Corp Risk Profiles
| Mean Deviation | 12.16 | |||
| Semi Deviation | 13.02 | |||
| Standard Deviation | 19.59 | |||
| Variance | 383.9 |
Entourage Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Entourage Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
Entourage Health Corporate Management
| Deborah Sikkema | Chief Officer | Profile | |
| Jeff Keyes | VP Operations | Profile | |
| Vaani Maharaj | Chief Officer | Profile | |
| George Scorsis | Ex CEO | Profile | |
| Joseph Mele | Chief Officer | Profile | |
| Alexandre Sibilev | VicePres Compliance | Profile | |
| Marianella delaBarrera | Sr Affairs | Profile |
Other Information on Investing in Entourage Pink Sheet
Entourage Health financial ratios help investors to determine whether Entourage Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Entourage with respect to the benefits of owning Entourage Health security.